FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to infectious diseases and paediatrics, and can be used to predict the course of chronic viral hepatitis C in children. Determining: glucose level, insulin level, calculating HOMA-IR index. It involves ultrasonic examination of abdominal cavity organs and liver elastography to determine presence of hepatic steatosis, hepatic fibrosis, hepatomegaly, pancreatic lipomatosis. Derived values are entered into the formulas for calculating the linear discriminant function – LDF1 – favourable clinical course of the disease and LDF2 – unfavourable clinical course of the disease. If LDF1 is more than LDF2, a favourable course of chronic viral hepatitis C in children is predicted, while LDF2 is more than LDF1 – an unfavourable course of the disease in children.
EFFECT: method can be used to increase the accuracy of predicting the clinical course of chronic viral hepatitis C due to the integrated assessment of laboratory and instrumental data.
1 cl, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING THE RISK OF LIVER FIBROSIS IN PATIENTS WITH OBESITY AND NON-ALCOHOLIC FATTY LIVER DISEASE | 2022 |
|
RU2794862C1 |
METHOD FOR DIAGNOSING THE STAGE OF LIVER FIBROSIS IN CHRONIC LIVER DISEASES IN CHILDREN | 2021 |
|
RU2763257C1 |
METHOD OF PREDICTING THE EFFECTIVENESS OF LITHOLYSIS IN CHOLELITHIASIS IN COMBINATION WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2023 |
|
RU2813033C1 |
METHOD FOR PREDICTING SEVERE HEPATIC FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2021 |
|
RU2765847C1 |
METHOD FOR PREDICTING NON-ALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2021 |
|
RU2765848C1 |
METHOD FOR PREDICTION OF PROGRESSIVE CLINICAL COURSE OF EARLY FORMS OF NON-ALCOHOLIC FATTY LIVER DISEASE | 2020 |
|
RU2768466C1 |
METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANYING METABOLIC SYNDROME | 2018 |
|
RU2686042C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF STEATOSIS AND NON-ALCOHOLIC STEATOHEPATITIS IN FEMALES | 2020 |
|
RU2744021C1 |
METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH METABOLIC SYNDROME WITH VITAMIN D DEFICIENCY | 2018 |
|
RU2694842C1 |
METHOD OF PERSONIFIED PREDICTION OF CLINICAL EFFECTIVENESS OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH METABOLIC SYNDROME | 2020 |
|
RU2737503C1 |
Authors
Dates
2025-01-22—Published
2024-05-07—Filed